Contact Us
Drug Search Results
More Filters [+]

JCAR-014

Alternative Names: jcar-014, jcar014, jcar 014
Latest Update: 2024-01-23
Latest Update Note: PubMed Publication

Product Description

anti-CD19-chimeric antigen receptor (CAR) lentiviral vector-transduced autologous T cells (Sourced from: https://www.clinicaltrials.gov/ct2/show/NCT02706405)

Mechanisms of Action: CAR-T,CD19

Novel Mechanism: No

Modality: Cell Therapy

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Fred Hutchinson Cancer Research Center
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for JCAR-014

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Lymphoma, Non-Hodgkin|Diffuse Large B-Cell Lymphoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
NCI-2015-02286

P1

Terminated

Diffuse Large B-Cell Lymphoma|Lymphoma, Non-Hodgkin

2021-05-28

Recent News Events

Date

Type

Title

01/23/2024

PubMed

 Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma.

06/30/2022

PubMed

 Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHL.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions